These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27183841)

  • 1. Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing?
    Hammond T; Allen P; Birdsall H
    Pharm Res; 2016 Jul; 33(7):1545-51. PubMed ID: 27183841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.
    Meng Q
    Expert Opin Drug Metab Toxicol; 2010 Jun; 6(6):733-46. PubMed ID: 20380484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
    Chang R; Emami K; Wu H; Sun W
    Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use.
    Schutte M; Fox B; Baradez MO; Devonshire A; Minguez J; Bokhari M; Przyborski S; Marshall D
    Assay Drug Dev Technol; 2011 Oct; 9(5):475-86. PubMed ID: 21675871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
    Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
    J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the development and use of human tissue-based techniques for drug toxicity testing.
    Clotworthy M; Archibald K
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1155-69. PubMed ID: 23687950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells.
    Csöbönyeiová M; Polák Š; Danišovič L
    Can J Physiol Pharmacol; 2016 Jul; 94(7):687-94. PubMed ID: 27128322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity tests for high-throughput drug discovery.
    Slater K
    Curr Opin Biotechnol; 2001 Feb; 12(1):70-4. PubMed ID: 11167076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized suspension culture: the rotating-wall vessel.
    Hammond TG; Hammond JM
    Am J Physiol Renal Physiol; 2001 Jul; 281(1):F12-25. PubMed ID: 11399642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tools to investigate and avoid drug-hypersensitivity in drug development.
    Corsini E; Casula M; Tragni E; Galbiati V; Pallardy M
    Expert Opin Drug Discov; 2018 May; 13(5):425-433. PubMed ID: 29405076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system.
    Nakamura K; Mizutani R; Sanbe A; Enosawa S; Kasahara M; Nakagawa A; Ejiri Y; Murayama N; Miyamoto Y; Torii T; Kusakawa S; Yamauchi J; Fukuda M; Yamazaki H; Tanoue A
    J Biosci Bioeng; 2011 Jan; 111(1):78-84. PubMed ID: 20837398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclinical development of biopharmaceuticals.
    Baumann A
    Drug Discov Today; 2009 Dec; 14(23-24):1112-22. PubMed ID: 19853058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of drug safety testing: expanding the view and narrowing the focus.
    Stevens JL; Baker TK
    Drug Discov Today; 2009 Feb; 14(3-4):162-7. PubMed ID: 19100337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs in control samples in nonclinical safety studies: a reconsideration.
    Zimmer D
    Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
    [No Abstract]   [Full Text] [Related]  

  • 16. New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.
    Bhushan A; Martucci NJ; Usta OB; Yarmush ML
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):475-7. PubMed ID: 26940609
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of major in vivo drug metabolic pathways using primary human hepatocytes and HepaRG cells in suspension and a dynamic three-dimensional bioreactor system.
    Darnell M; Ulvestad M; Ellis E; Weidolf L; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):134-44. PubMed ID: 22776955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates.
    Kramer JA; Sagartz JE; Morris DL
    Nat Rev Drug Discov; 2007 Aug; 6(8):636-49. PubMed ID: 17643090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.
    Li AP; Uzgare A; LaForge YS
    Chem Biol Interact; 2012 Jul; 199(1):1-8. PubMed ID: 22640811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.